Brief: Ocumension Therapeutics Announces Disposal Of Shares In Eyepoint Pharmaceuticals
17/01/2024 01:33
Jan 17 (Reuters) - Ocumension Therapeutics 1477.HK :
* DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC.
* DISPOSAL AT AGGREGATE CONSIDERATION OF $56.7 MILLION
* DISPOSED OF 2.9 MILLION EYEPOINT SHARES DURING PERIOD MAY
30 TO
DEC 6, 2023 AND ON JAN 11
* NET PROCEEDS FROM DISPOSALS ARE EXPECTED TO BE
APPROXIMATELY
RMB402.78 MILLION
Source text for Eikon: ID:n11040409-1
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application